Literature DB >> 23397055

Impaired function of prejunctional adenosine A1 receptors expressed by perivascular sympathetic nerves in DOCA-salt hypertensive rats.

Sutheera Sangsiri1, Hua Dong, Gregory M Swain, James J Galligan, Hui Xu.   

Abstract

Increased sympathetic nervous system activity contributes to deoxycorticosterone acetate (DOCA)-salt hypertension in rats. ATP and norepinephrine (NE) are coreleased from perivascular sympathetic nerves. NE acts at prejunctional α2-adrenergic receptors (α2ARs) to inhibit NE release, and α2AR function is impaired in DOCA-salt rats. Adenosine, an enzymatic ATP degradation product, acts at prejunctional A1 adenosine receptors (A1Rs) to inhibit NE release. We tested the hypothesis that prejunctional A1R function is impaired in sympathetic nerves supplying mesenteric arteries (MAs) and veins (MVs) of DOCA-salt rats. Electrically evoked NE release and constrictions of blood vessels were studied in vitro with use of amperometry to measure NE oxidation currents and video microscopy, respectively. Immunohistochemical methods were used to localize tyrosine hydroxylase (TH) and A1Rs in perivascular sympathetic nerves. TH and A1Rs colocalized to perivascular sympathetic nerves. Adenosine and N(6)-cyclopentyl-adenosine (CPA, A1R agonist) constricted MVs but not MAs. Adenosine and CPA (0.001-10 µM) inhibited neurogenic constrictions and NE release in MAs and MVs. DOCA-salt arteries were resistant to adenosine and CPA-mediated inhibition of NE release and constriction. The A2A adenosine receptor agonist CGS21680 (C23H29N7O6.HCl.xH2O) (0.001-0.1 μM) did not alter NE oxidation currents. We conclude that there are prejunctional A1Rs in arteries and both pre- and postjunctional A1Rs in veins; thus, adenosine selectively constricts the veins. Prejunctional A1R function is impaired in arteries, but not veins, from DOCA-salt rats. Sympathetic autoreceptor dysfunction is not specific to α2ARs, but there is a more general disruption of prejunctional mechanisms controlling sympathetic neurotransmitter release in DOCA-salt hypertension.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23397055      PMCID: PMC3608448          DOI: 10.1124/jpet.112.199612

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  39 in total

Review 1.  ATP as a cotransmitter in sympathetic nerves and its inactivation by releasable enzymes.

Authors:  David P Westfall; Latchezar D Todorov; Svetlana T Mihaylova-Todorova
Journal:  J Pharmacol Exp Ther       Date:  2002-11       Impact factor: 4.030

2.  Sympathoinhibition by adenosine A(1) receptors, but not P2 receptors, in the hamster mesenteric arterial bed.

Authors:  V Ralevic
Journal:  Eur J Pharmacol       Date:  2000-01-17       Impact factor: 4.432

3.  Impaired function of alpha2-adrenergic autoreceptors on sympathetic nerves associated with mesenteric arteries and veins in DOCA-salt hypertension.

Authors:  Min Luo; Gregory D Fink; Keith J Lookingland; John A Morris; James J Galligan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-12-11       Impact factor: 4.733

4.  Antioxidant treatment restores prejunctional regulation of purinergic transmission in mesenteric arteries of deoxycorticosterone acetate-salt hypertensive rats.

Authors:  S L Demel; H Dong; G M Swain; X Wang; D L Kreulen; J J Galligan
Journal:  Neuroscience       Date:  2010-04-14       Impact factor: 3.590

Review 5.  Pharmacology of adenosine receptors in the vasculature.

Authors:  R Tabrizchi; S Bedi
Journal:  Pharmacol Ther       Date:  2001-08       Impact factor: 12.310

6.  Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes.

Authors:  S Ginés; J Hillion; M Torvinen; S Le Crom; V Casadó; E I Canela; S Rondin; J Y Lew; S Watson; M Zoli; L F Agnati; P Verniera; C Lluis; S Ferré; K Fuxe; R Franco
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

7.  Release inhibitory receptors activation favours the A2A-adenosine receptor-mediated facilitation of noradrenaline release in isolated rat tail artery.

Authors:  Paula Fresco; Carmen Diniz; Glória Queiroz; Jorge Gonçalves
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

8.  Adenosine A(2A) receptors in portal hypertension: their role in the abnormal response to adenosine of the cranial mesenteric artery in rabbits.

Authors:  M T Villa de Brito; A Canto; J H Duarte Correia; R A Cunha; M C Marques
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

Review 9.  Hypertension due to blockade of adenosine receptors.

Authors:  Serafim Guimarães; Manuela Morato; Teresa Sousa; António Albino-Teixeira
Journal:  Pharmacol Toxicol       Date:  2003-04

10.  Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation.

Authors:  Markus P Schlaich; Elisabeth Lambert; David M Kaye; Zygmunt Krozowski; Duncan J Campbell; Gavin Lambert; Jacqui Hastings; Anuradha Aggarwal; Murray D Esler
Journal:  Hypertension       Date:  2003-11-10       Impact factor: 10.190

View more
  6 in total

1.  Spinal cord injury alters purinergic neurotransmission to mesenteric arteries in rats.

Authors:  Sutheera Sangsiri; Hui Xu; Roxanne Fernandes; Greg D Fink; Heidi L Lujan; Stephen E DiCarlo; James J Galligan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-11-27       Impact factor: 4.733

2.  Vascular impairment of adenosinergic system in hypertension: increased adenosine bioavailability and differential distribution of adenosine receptors and nucleoside transporters.

Authors:  Ana Sousa-Oliveira; Ana Brandão; Martin Vojtek; Salomé Gonçalves-Monteiro; Joana B Sousa; Carmen Diniz
Journal:  Histochem Cell Biol       Date:  2018-10-24       Impact factor: 4.304

3.  Macrophage depletion lowers blood pressure and restores sympathetic nerve α2-adrenergic receptor function in mesenteric arteries of DOCA-salt hypertensive rats.

Authors:  Loc V Thang; Stacie L Demel; Robert Crawford; Norbert E Kaminski; Greg M Swain; Nico Van Rooijen; James J Galligan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-28       Impact factor: 4.733

4.  Adenosine Receptor-Mediated Cardioprotection-Current Limitations and Future Directions.

Authors:  Robert D Lasley
Journal:  Front Pharmacol       Date:  2018-04-04       Impact factor: 5.810

Review 5.  The Adenosinergic System as a Therapeutic Target in the Vasculature: New Ligands and Challenges.

Authors:  Joana Beatriz Sousa; Carmen Diniz
Journal:  Molecules       Date:  2017-05-06       Impact factor: 4.411

6.  Activation of neuronal adenosine A1 receptors causes hypothermia through central and peripheral mechanisms.

Authors:  Haley S Province; Cuiying Xiao; Allison S Mogul; Ankita Sahoo; Kenneth A Jacobson; Ramón A Piñol; Oksana Gavrilova; Marc L Reitman
Journal:  PLoS One       Date:  2020-12-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.